
Clovis Oncology (CLVS) Earnings Dates & Reports
Clovis Oncology (CLVS) Most Recent Earnings
Report DateNov 9, 2022
Period EndingQ3 2022
Est. EPS-$0.37
Actual EPS-$0.39
EarningsMiss
Clovis Oncology (CLVS) Earnings
View the latest Clovis Oncology (CLVS) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Clovis Oncology (CLVS)
Order type
Buy in
Order amount
Est. shares
0 shares
Clovis Oncology (CLVS) Earnings per Share (EPS) History
Signup for full accessBrowse free
Clovis Oncology (CLVS) Latest Earnings
The value each CLVS share was expected to gain vs. the value each share gained.
Clovis Oncology (CLVS) reported its most recent earnings on Nov 9, 2022 for Q3 2022, posting earnings per share (EPS) of -$0.39. This exceeded analysts' expectations of -$0.37 by 5.41%, marking a Miss.
For comparison, Clovis Oncology reported EPS of -$0.56 in the same quarter last year.
The company is expected to announce its next earnings report on 11/09/2022, with analysts projecting an EPS of $0.
Clovis Oncology (CLVS) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q3 2022Nov 9, 2022 | -$0.37 | -$0.39 | +5.41% | |
Q2 2022Aug 8, 2022 | -$0.41 | -$0.50 | +21.95% | |
Q1 2022May 4, 2022 | -$0.43 | -$0.44 | +2.33% | |
Q4 2021Feb 23, 2022 | -$0.56 | -$0.48 | -14.29% | |
Q3 2021Nov 3, 2021 | -$0.48 | -$0.56 | +16.67% | |
Clovis Oncology (CLVS) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Clovis Oncology’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Aug 8, 2022 | — | — | — |
May 4, 2022 | — | — | — |
Feb 23, 2022 | — | — | — |
Nov 3, 2021 | — | — | — |
Clovis Oncology (CLVS) Earnings FAQs
Clovis Oncology (CLVS) last reported earnings on Nov 9, 2022 for Q3 2022, posting an EPS of -$0.39, which Miss the estimate of -$0.37 by 5.41%.
For Q3 2022, Clovis Oncology (CLVS) reported an EPS of -$0.39, missing analysts' estimate of -$0.37 by 5.41%.
For Q3 2022, Clovis Oncology (CLVS) Miss expectations with an actual EPS of -$0.39 vs. an estimated EPS of -$0.37.
Following the last earnings report on Nov 9, 2022, Clovis Oncology (CLVS)'s stock price moved — from — to —.
The next Clovis Oncology (CLVS) earnings call is scheduled for Nov. 9, 2022, where executives will discuss financial results and outlook.